Cite

MLA Citation

    A Bar-Gil Shitrit et al.. “P635 Risankizumab - real world Israeli data in severe refractory IBD patients.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i767–i768. http://access.bl.uk/ark:/81055/vdc_100179844278.0x00000f
  
Back to record